SEC Form 4 · accession 0001607737-26-000008
Jazz Pharmaceuticals plc · JAZZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Renee D Gala
Officer — President & CEO
Period of report
Jun 3, 2026
Accepted (ET)
Jun 5, 2026 · 4:40 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001232524
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF2 | Jun 3, 2026 | G | 600 | $0.00 | D | 152,196 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares were donated to The Gala Family Fund, a donor-advised fund.
- F2The Reporting Person acquired 166 ordinary shares under a Section 423 Employee Stock Purchase Plan on May 29, 2026.